# Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery

> **NCT07479446** · NA · NOT_YET_RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 174 (estimated)

## Conditions studied

- PONV
- Cerebellopontine Angle Tumor
- Microvascular Decompression Surgery
- Postoperative Analgesia

## Interventions

- **DRUG:** Oliceridine
- **DRUG:** Sufentanil

## Key facts

- **NCT ID:** NCT07479446
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-09-30
- **Target enrollment:** 174 (ESTIMATED)
- **Last updated:** 2026-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07479446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07479446, "Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07479446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*